Avelas Biosciences, Inc.

Sep 26, 2018

Avelas Biosciences to Present at 2018 Cantor Global Healthcare Conference

Jun 14, 2018

Avelas Biosciences to Present at JMP Securities Annual Life Sciences Conference

Mar 21, 2018

Avelas Biosciences to Present at Needham & Company 17th Annual Healthcare Conference

Mar 13, 2018

Avelas Biosciences to Present at Oppenheimer 28th Annual Healthcare Conference

Jan 04, 2018

Avelas Biosciences Completes Period 1 Patient Enrollment in Phase 2 Study of AVB-620 in Women with Primary, Nonrecurrent Breast Cancer Undergoing Surgery

Jan 03, 2018

Avelas Biosciences Broadens Management Team with Key Executive Additions

Nov 21, 2017

Avelas Biosciences to Present at Piper Jaffray Healthcare Conference

Sep 26, 2017

Newly Published Data Supports Avelas Biosciences' Investigational Ratiometric Activatable Fluorescent Peptide AVB-620 in Intraoperative Tumor Detection

Sep 14, 2017

Avelas Biosciences' AVB-620 Shows Sensitive In Vivo Visualization of Breast Cancer in Journal Publication

Aug 03, 2017

Avelas Biosciences Doses First Patient in Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

Jun 13, 2017

Avelas Biosciences to Participate in JMP Securities Life Sciences Conference